Table 3. VAMS factor scores before and after behavioral tests and the three-way repeated measures ANOVA results.
| VAMS factor/phase | Cannabidiol
(n=17) (mean [SD]) |
Placebo
(n=16) (mean [SD]) |
Interaction | |||
|---|---|---|---|---|---|---|
| Phase | Phase x group | Phase x trauma | Phase x group x trauma | |||
| Anxiety | F1,29 = 73.7 (p < 0.001)*
ηp 2 = 0.72 |
F1,29 = 0.38 (p = 0.54)
ηp 2 = 0.01 |
F1,29 = 1.03 (p = 0.32)
ηp 2 = 0.03 |
F1,29 = 3.60 (p = 0.07)*
ηp 2 = 0.11 |
||
| Before | 40.34 (14.55) | 36.77 (14.92) | ||||
| After | 54.94 (15.05) | 55.00 (12.57) | ||||
| Sedation | F1,29 = 28.6 (p < 0.001)*
ηp 2 = 0.50 |
F1,29 = 0.69 (p = 0.41)
ηp 2 = 0.02 |
F1,29 = 3.22 (p = 0.08)**
ηp 2 = 0.10 |
F1,29 = 0.29 (p = 0.60)
ηp 2 = 0.01 |
||
| Before | 58.52 (10.40) | 54.34 (14.53) | ||||
| After | 42.23 (14.82) | 42.03 (13.55) | ||||
| Cognitive impairment | F1,29 = 23.4 (p < 0.001)*
ηp 2 = 0.45 |
F1,29 = 4.28 (p = 0.048)**
ηp 2 = 0.13 |
F1,29 = 0.03 (p = 0.86)
ηp 2 = 0.001 |
F1,29 = 0.61 (p = 0.44)
ηp 2 = 0.02 |
||
| Before | 45.40 (11.69) | 43.36 (11.95) | ||||
| After | 49.15 (13.01) | 53.41 (15.78) | ||||
| Discomfort | F1,29 = 29.8 (p < 0.001)*
ηp 2 = 0.51 |
F1,29 = 0.14 (p = 0.72)
ηp 2 = 0.005 |
F1,29 = 0.12 (p =0.72)
ηp 2 = 0.004 |
F1,29 = 4.48 (p = 0.043)*
ηp 2 = 0.13 |
||
| Before | 37.71 (11.8) | 40.86 (11.81) | ||||
| After | 46.90 (12.21) | 49.84 (11.16) | ||||
ANOVA = analysis of variance; VAMS = Visual Analog Mood Scale.
*
p < 0,05;
**
p > 0.05 and < 0.1.